| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A comparative trial of risedronate vs. etidronate in the treatment of patients with Paget’s disease of bone
|
Miller, P.D
|
|
1999
|
|
5S1 |
p. 93S-
1 p.
|
article
|
| 2 |
Adult bone and mineral working group
|
|
|
1998
|
|
5S1 |
p. S74-
1 p.
|
article
|
| 3 |
Advanced imaging surrogates of bone strength
|
Müller, Ralph
|
|
2007
|
|
5S1 |
p. S33-
1 p.
|
article
|
| 4 |
Afternoon concurrent oral sessions
|
|
|
1998
|
|
5S1 |
p. S109-S110
2 p.
|
article
|
| 5 |
Afternoon concurrent oral sessions
|
|
|
1998
|
|
5S1 |
p. S116-S142
27 p.
|
article
|
| 6 |
A marker for type I collagen degradation identified in urine from patients with Paget’s disease of bone
|
Krane, S.M
|
|
1999
|
|
5S1 |
p. 52S-
1 p.
|
article
|
| 7 |
A multicenter study of chromosome 18q linkage in familial Paget’s disease
|
Hocking, L.J
|
|
1999
|
|
5S1 |
p. 31S-
1 p.
|
article
|
| 8 |
Analgesic effect of calcitonin in osteoporosis
|
Gennari, C
|
|
2002
|
|
5S1 |
p. 67-70
4 p.
|
article
|
| 9 |
Analgesic effects of calcitonin
|
Lyritis, G.P
|
|
2002
|
|
5S1 |
p. 71-74
4 p.
|
article
|
| 10 |
A new radioimmunoassay for C-terminal telopeptide of type I collagen in the diagnosis and follow-up of Paget’s disease
|
Gonnelli, S
|
|
1999
|
|
5S1 |
p. 52S-
1 p.
|
article
|
| 11 |
Animal-related risk factors in Spanish patients with Paget’s disease of bone
|
Morales-Piga, A
|
|
1999
|
|
5S1 |
p. 15S-
1 p.
|
article
|
| 12 |
Announcements
|
|
|
1995
|
|
5S1 |
p. S521-
1 p.
|
article
|
| 13 |
Antifracture efficacy of strontium ranelate in postmenopausal osteoporosis
|
Roux, Christian
|
|
2007
|
|
5S1 |
p. S9-S11
3 p.
|
article
|
| 14 |
A Nude Mouse Model for Human Bone Formation in Unloaded Conditions
|
Muraglia, A
|
|
1998
|
|
5S1 |
p. 131S-134S
nvt p.
|
article
|
| 15 |
A randomized treatment trial of intravenous pamidronate and oral alendronate in Paget’s disease: early results
|
Gutteridge, D.H
|
|
1999
|
|
5S1 |
p. 67S-68S
nvt p.
|
article
|
| 16 |
Are paramyxoviruses involved in paget’s disease? A negative view
|
Ralston, S.H
|
|
1999
|
|
5S1 |
p. 17S-18S
nvt p.
|
article
|
| 17 |
ASBMR awards dinner
|
|
|
1998
|
|
5S1 |
p. S39-
1 p.
|
article
|
| 18 |
ASBMR business meeting
|
|
|
1998
|
|
5S1 |
p. S73-
1 p.
|
article
|
| 19 |
ASBMR-IBMS banquet & awards ceremony
|
|
|
1998
|
|
5S1 |
p. S143-S144
2 p.
|
article
|
| 20 |
ASBMR-IBMS dance & cash bar
|
|
|
1998
|
|
5S1 |
p. S145-
1 p.
|
article
|
| 21 |
ASMBR-IBMS reception at the San Francisco museum of modern art
|
|
|
1998
|
|
5S1 |
p. S79-
1 p.
|
article
|
| 22 |
Author index
|
|
|
1998
|
|
5S1 |
p. S681-S708
28 p.
|
article
|
| 23 |
Author index
|
|
|
2001
|
|
5S1 |
p. S275-S286
12 p.
|
article
|
| 24 |
Biochemical markers of bone turnover in Paget’s disease of bone
|
Eastell, R
|
|
1999
|
|
5S1 |
p. 49S-50S
nvt p.
|
article
|
| 25 |
Biochemical markers of bone turnover in predicting response to clodronate therapy in Paget’s disease
|
Parker, C.R.
|
|
1999
|
|
5S1 |
p. 68S-
1 p.
|
article
|
| 26 |
Bisphosphonate action on bone structure and strength: Preclinical and clinical evidence for ibandronate
|
Müller, Ralph
|
|
2007
|
|
5S1 |
p. S16-S23
8 p.
|
article
|
| 27 |
Bisphosphonate antifracture efficacy
|
Adami, Silvano
|
|
2007
|
|
5S1 |
p. S8-S15
8 p.
|
article
|
| 28 |
Bisphosphonates: The evolution of a gold standard
|
Russell, Graham
|
|
2007
|
|
5S1 |
p. S29-
1 p.
|
article
|
| 29 |
Bone remodelling and antifracture efficacy of oral bisphosphonate therapy
|
Papapoulos, Socrates E.
|
|
2007
|
|
5S1 |
p. S32-
1 p.
|
article
|
| 30 |
Calcaneus as a Site for the Assessment of Bone Mass
|
Sone, T
|
|
1998
|
|
5S1 |
p. 155S-157S
nvt p.
|
article
|
| 31 |
Calcitonin, an update
|
Martin, T.J
|
|
1999
|
|
5S1 |
p. 63S-65S
nvt p.
|
article
|
| 32 |
Calcitonin for the long-term prevention and treatment of postmenopausal osteoporosis
|
Body, J.-J
|
|
2002
|
|
5S1 |
p. 75-79
5 p.
|
article
|
| 33 |
Calcitonin in osteoporosis
|
Kanis, J.A.
|
|
2002
|
|
5S1 |
p. 65-66
2 p.
|
article
|
| 34 |
Calcitonin in reflex sympathetic dystrophy syndrome and other painful conditions
|
Appelboom, T
|
|
2002
|
|
5S1 |
p. 84-86
3 p.
|
article
|
| 35 |
Cellular and molecular regulation of bone turnover
|
Mundy, G.R
|
|
1999
|
|
5S1 |
p. 35S-38S
nvt p.
|
article
|
| 36 |
Concurrent oral session 27 Bone, cartilage and connective tissue matrix II
|
|
|
1998
|
|
5S1 |
p. S147-
1 p.
|
article
|
| 37 |
Concurrent oral session 1 Bone cells: Osteoblasts I
|
|
|
1998
|
|
5S1 |
p. S5-
1 p.
|
article
|
| 38 |
Concurrent oral session 3 Bone cells: Osteoblasts II
|
|
|
1998
|
|
5S1 |
p. S35-S36
2 p.
|
article
|
| 39 |
Concurrent oral session 9 Bone cells: Osteoclasts I
|
|
|
1998
|
|
5S1 |
p. S71-S72
2 p.
|
article
|
| 40 |
Concurrent oral session 2 Osteoporosis: Epidemiology I
|
|
|
1998
|
|
5S1 |
p. S6-
1 p.
|
article
|
| 41 |
Concurrent oral session 12 Osteoporosis: Epidemiology II
|
|
|
1998
|
|
5S1 |
p. S73-
1 p.
|
article
|
| 42 |
Concurrent oral session 7 Osteoporosis: Genetics
|
|
|
1998
|
|
5S1 |
p. S41-
1 p.
|
article
|
| 43 |
Concurrent oral session 8 Peptide calciotropic hormones II
|
|
|
1998
|
|
5S1 |
p. S42-S71
30 p.
|
article
|
| 44 |
Concurrent plenary lectures
|
|
|
1998
|
|
5S1 |
p. S114-
1 p.
|
article
|
| 45 |
Concurrent plenary lectures
|
|
|
1998
|
|
5S1 |
p. S81-
1 p.
|
article
|
| 46 |
Concurrent plenary lectures
|
|
|
1998
|
|
5S1 |
p. S41-
1 p.
|
article
|
| 47 |
Concurrent plenary lectures
|
|
|
1998
|
|
5S1 |
p. S78-
1 p.
|
article
|
| 48 |
Considerations in building the evidence in osteoporosis management
|
Reginster, Jean-Yves
|
|
2007
|
|
5S1 |
p. S30-S31
2 p.
|
article
|
| 49 |
Contact information
|
|
|
2001
|
|
5S1 |
p. v-
1 p.
|
article
|
| 50 |
Continuous combined HRT and bisphosphonates in osteoporosis: Similarities and differences
|
Kanis, J.A.
|
|
1996
|
|
5S1 |
p. 177S-
1 p.
|
article
|
| 51 |
Current bone mineral density data on bisphosphonates in postmenopausal osteoporosis
|
McClung, M.R.
|
|
1996
|
|
5S1 |
p. 195S-198S
nvt p.
|
article
|
| 52 |
Day-at-a-glance
|
|
|
1998
|
|
5S1 |
p. S1-
1 p.
|
article
|
| 53 |
Day-at-a-glance
|
|
|
1998
|
|
5S1 |
p. S113-
1 p.
|
article
|
| 54 |
Day-at-a-glance
|
|
|
1998
|
|
5S1 |
p. S145-
1 p.
|
article
|
| 55 |
Day-at-a-glance
|
|
|
1998
|
|
5S1 |
p. S4-
1 p.
|
article
|
| 56 |
Day-at-a-glance
|
|
|
1998
|
|
5S1 |
p. S40-
1 p.
|
article
|
| 57 |
Day-at-a-glance
|
|
|
1998
|
|
5S1 |
p. S77-
1 p.
|
article
|
| 58 |
Day-at-glance
|
|
|
1998
|
|
5S1 |
p. S80-
1 p.
|
article
|
| 59 |
Demonstration of canine distemper virus in pagetic bone: possible explanation for failure to detect viruses using reverse transcriptase-polymerase chain reaction
|
Dixon, J.A
|
|
1999
|
|
5S1 |
p. 27S-
1 p.
|
article
|
| 60 |
Determinants of bone strength and clinical practice; effects of bisphosphonates
|
Papapoulos, Socrates E.
|
|
2007
|
|
5S1 |
p. S3-S7
5 p.
|
article
|
| 61 |
Direct identification of osteoblast progenitor cells in Paget’s disease
|
Joyner, C.J
|
|
1999
|
|
5S1 |
p. 41S-
1 p.
|
article
|
| 62 |
Editorial
|
|
|
1998
|
|
5S1 |
p. 101S-102S
nvt p.
|
article
|
| 63 |
Editorial
|
|
|
1998
|
|
5S1 |
p. 117S-118S
nvt p.
|
article
|
| 64 |
Editorial
|
|
|
1998
|
|
5S1 |
p. 71S-
1 p.
|
article
|
| 65 |
Editorial
|
|
|
1998
|
|
5S1 |
p. 159S-161S
nvt p.
|
article
|
| 66 |
Editorial
|
|
|
1998
|
|
5S1 |
p. 135S-137S
nvt p.
|
article
|
| 67 |
Editorial
|
|
|
1999
|
|
5S1 |
p. I-II
nvt p.
|
article
|
| 68 |
Editorial
|
|
|
1999
|
|
5S1 |
p. III-
1 p.
|
article
|
| 69 |
Editorial Board
|
|
|
1998
|
|
5S1 |
p. i-
1 p.
|
article
|
| 70 |
Editorial Board
|
|
|
2007
|
|
5S1 |
p. i-ii
nvt p.
|
article
|
| 71 |
Editorial Board
|
|
|
2007
|
|
5S1 |
p. i-ii
nvt p.
|
article
|
| 72 |
Effect of Mechanical Unloading and Reloading on Periosteal Bone Formation and Gene Expression in Tail-Suspended Rapidly Growing Rats
|
Matsumoto, T
|
|
1998
|
|
5S1 |
p. 89S-93S
nvt p.
|
article
|
| 73 |
Effect of 10 years' hormone replacement therapy on bone mineral content in postmenopausal women
|
Eiken, P.
|
|
1996
|
|
5S1 |
p. 191S-193S
nvt p.
|
article
|
| 74 |
Effects of Gravitational Changes on the Bone System In Vitro and In Vivo
|
Vico, L
|
|
1998
|
|
5S1 |
p. 95S-100S
nvt p.
|
article
|
| 75 |
Efficacy and safety of drugs for Paget's disease of bone
|
Reginster, J.-Y.L.
|
|
1995
|
|
5S1 |
p. S485-S488
4 p.
|
article
|
| 76 |
Epidemiological, clinical, biochemical, and imaging characteristics of monostotic and polyostotic Paget’s disease
|
Monfort, J
|
|
1999
|
|
5S1 |
p. 13S-14S
nvt p.
|
article
|
| 77 |
Epidemiology of Paget’s disease of bone
|
Cooper, C
|
|
1999
|
|
5S1 |
p. 3S-5S
nvt p.
|
article
|
| 78 |
Estrogens, the menopause, and osteoporosis
|
Kanis, J.A.
|
|
1996
|
|
5S1 |
p. 185S-190S
nvt p.
|
article
|
| 79 |
European and North American experience with HRT for the prevention of osteoporosis
|
Eriksen, E.F.
|
|
1996
|
|
5S1 |
p. 179S-183S
nvt p.
|
article
|
| 80 |
Evening at the opera/theater/symphony
|
|
|
1998
|
|
5S1 |
p. S79-
1 p.
|
article
|
| 81 |
Faculty committees
|
|
|
2001
|
|
5S1 |
p. vi-viii
nvt p.
|
article
|
| 82 |
Failure to detect paramyxovirus RNA in bone and osteoblast-like and osteoclast-like cells cultured from patients with Paget’s disease
|
Ooi, C.G
|
|
1999
|
|
5S1 |
p. 27S-
1 p.
|
article
|
| 83 |
Family history and heritability of Paget’s disease: a multicenter study
|
Slee, F.
|
|
1999
|
|
5S1 |
p. 32S-
1 p.
|
article
|
| 84 |
Floorplan
|
|
|
2001
|
|
5S1 |
p. A5-A7
nvt p.
|
article
|
| 85 |
Foreword
|
Papapoulos, Socrates E.
|
|
2007
|
|
5S1 |
p. S2-
1 p.
|
article
|
| 86 |
Free afternoon
|
|
|
1998
|
|
5S1 |
p. S79-
1 p.
|
article
|
| 87 |
Future Human Bone Research in Space
|
LeBlanc, A
|
|
1998
|
|
5S1 |
p. 113S-116S
nvt p.
|
article
|
| 88 |
Gene Expression Related to the Differentiation of Osteoblastic Cells Is Altered by Microgravity
|
Carmeliet, G
|
|
1998
|
|
5S1 |
p. 139S-143S
nvt p.
|
article
|
| 89 |
General information
|
|
|
2001
|
|
5S1 |
p. xi-xii
nvt p.
|
article
|
| 90 |
Genetic epidemiology of Paget’s disease of bone in Eastern Québec
|
Brown, J.P
|
|
1999
|
|
5S1 |
p. 15S-
1 p.
|
article
|
| 91 |
Genetic linkage of Paget’s disease to chromosome 18q in a French pedigree
|
Lucotte, G.
|
|
1999
|
|
5S1 |
p. 31S-
1 p.
|
article
|
| 92 |
Hindlimb Unloading of Growing Rats: A Model for Predicting Skeletal Changes During Space Flight
|
Morey-Holton, E.R
|
|
1998
|
|
5S1 |
p. 83S-88S
nvt p.
|
article
|
| 93 |
Human osteoblasts support human monocyte-osteoclast differentiation: evidence of prostaglandin stimulation
|
Neale, S.D
|
|
1999
|
|
5S1 |
p. 41S-
1 p.
|
article
|
| 94 |
Human pharmacokinetics of tiludronate
|
Sansom, L.N.
|
|
1995
|
|
5S1 |
p. S479-S483
5 p.
|
article
|
| 95 |
Ibandronate: An IV injection for the treatment for postmenopausal osteoporosis
|
Rizzoli, René
|
|
2007
|
|
5S1 |
p. S24-S28
5 p.
|
article
|
| 96 |
Ibandronate treatment in Paget’s disease of bone
|
Grauer, A
|
|
1999
|
|
5S1 |
p. 87S-89S
nvt p.
|
article
|
| 97 |
IBMS business meeting
|
|
|
1998
|
|
5S1 |
p. S111-
1 p.
|
article
|
| 98 |
IBMS-ECTS 2001
|
|
|
2001
|
|
5S1 |
p. i-
1 p.
|
article
|
| 99 |
Immuno terminal domain of Smad1 interacting with Hoxc-8 is sufficient to induce bone cell differentiation
|
Yang, X.
|
|
1998
|
|
5S1 |
p. S147-S148
2 p.
|
article
|
| 100 |
Impaired intramembranous bone formation in connexin43 null mice
|
Lecanda, Fernando
|
|
1998
|
|
5S1 |
p. S149-S653
505 p.
|
article
|
| 101 |
Infrequent neurological manifestations in Paget’s disease of bone
|
Porrini, A.A
|
|
1999
|
|
5S1 |
p. 16S-
1 p.
|
article
|
| 102 |
Intravenous administration: International perspectives
|
Hadji, Peyman
|
|
2007
|
|
5S1 |
p. S44-
1 p.
|
article
|
| 103 |
Intravenous bisphosphonate safety: The realities
|
Miller, Paul D.
|
|
2007
|
|
5S1 |
p. S42-S43
2 p.
|
article
|
| 104 |
Introduction
|
Bouillon, Roger
|
|
2007
|
|
5S1 |
p. S1-
1 p.
|
article
|
| 105 |
In vivo working group
|
|
|
1998
|
|
5S1 |
p. S76-
1 p.
|
article
|
| 106 |
Isolation of novel genes in Paget’s disease by subtractive hybridization
|
Dixon, J.A
|
|
1999
|
|
5S1 |
p. 32S-
1 p.
|
article
|
| 107 |
Israeli Arabs do have Paget’s disease of bone
|
Dolev, E
|
|
1999
|
|
5S1 |
p. 15S-
1 p.
|
article
|
| 108 |
Key word index
|
|
|
1998
|
|
5S1 |
p. S655-S680
26 p.
|
article
|
| 109 |
Lessons from the Space Experiment SL-J/FMPT/L7: The Effect of Microgravity on Chicken Embryogenesis and Bone Formation
|
Suda, T
|
|
1998
|
|
5S1 |
p. 73S-78S
nvt p.
|
article
|
| 110 |
Lipoprotein(a) serum levels in patients with Paget’s disease and primary hyperparathyroidism
|
Adami, S
|
|
1999
|
|
5S1 |
p. 32S-33S
nvt p.
|
article
|
| 111 |
Long-lasting suppression of Paget’s disease activity with cyclical tiludronate treatment
|
Ringe, J.D
|
|
1999
|
|
5S1 |
p. 68S-
1 p.
|
article
|
| 112 |
Long-term follow-up of Paget’s disease: progression despite medical treatment
|
Phillips, A.J
|
|
1999
|
|
5S1 |
p. 51S-
1 p.
|
article
|
| 113 |
Maintaining the life-long vitality and integrity of skeletal tissue
|
Raisz, Lawrence G.
|
|
2007
|
|
5S1 |
p. S1-S4
4 p.
|
article
|
| 114 |
Managing the osteoporotic patient today
|
Reginster, Jean-Yves
|
|
2007
|
|
5S1 |
p. S12-S18
7 p.
|
article
|
| 115 |
Mechanisms of abnormal bone turnover in Paget’s disease
|
Roodman, G.David
|
|
1999
|
|
5S1 |
p. 39S-40S
nvt p.
|
article
|
| 116 |
Medical Baseline Data Collection on Bone and Muscle Change with Space Flight
|
Miyamoto, A
|
|
1998
|
|
5S1 |
p. 79S-82S
nvt p.
|
article
|
| 117 |
Meet-the-NIH-and-other-funding-sources
|
|
|
1998
|
|
5S1 |
p. S82-
1 p.
|
article
|
| 118 |
Microgravity and Bone Cell Mechanosensitivity
|
Burger, E.H
|
|
1998
|
|
5S1 |
p. 127S-130S
nvt p.
|
article
|
| 119 |
Molecular biology and the pathology of bone working group
|
|
|
1998
|
|
5S1 |
p. S112-
1 p.
|
article
|
| 120 |
Molecular mechanisms of action of bisphosphonates
|
Rogers, M.J
|
|
1999
|
|
5S1 |
p. 73S-79S
nvt p.
|
article
|
| 121 |
Monthly ibandronate: Offering an adherence advantage
|
Stone, Mike
|
|
2007
|
|
5S1 |
p. S38-S39
2 p.
|
article
|
| 122 |
Morning concurrent oral sessions
|
|
|
1998
|
|
5S1 |
p. S115-
1 p.
|
article
|
| 123 |
Morning concurrent oral sessions
|
|
|
1998
|
|
5S1 |
p. S81-
1 p.
|
article
|
| 124 |
Morning current oral sessions
|
|
|
1998
|
|
5S1 |
p. S78-
1 p.
|
article
|
| 125 |
Noninvasive Assessment of Bone Density and Structure Using Computed Tomography and Magnetic Resonance 1 1 This manuscript was partially adapted from Genant, H., Engelke, K., Fuerst, T. Gluer, C. C., Grampp, S., Harris, S. T., Jergas, M., Lang, T., Lu, Y., and Majumdar S. Non-invasive assessment of bone mineral and structure: State of the art. J Bone Miner Res 11:707–729; 1996.
|
Lang, T
|
|
1998
|
|
5S1 |
p. 149S-153S
nvt p.
|
article
|
| 126 |
Non-invasive assessment of trabecular bone microarchitecture working group
|
|
|
1998
|
|
5S1 |
p. S2-
1 p.
|
article
|
| 127 |
Nutrition and bone health working group
|
|
|
1998
|
|
5S1 |
p. S113-
1 p.
|
article
|
| 128 |
Official social program
|
|
|
2001
|
|
5S1 |
p. xiii-
1 p.
|
article
|
| 129 |
On Mechanosensation in Bone Under Microgravity
|
Cowin, S.C
|
|
1998
|
|
5S1 |
p. 119S-125S
nvt p.
|
article
|
| 130 |
Opening address and announcements
|
|
|
1998
|
|
5S1 |
p. S5-
1 p.
|
article
|
| 131 |
Oral presentations
|
|
|
2001
|
|
5S1 |
p. S70-S89
20 p.
|
article
|
| 132 |
Origin of a therapy: The evolution of intravenous bisphosphonates
|
Recker, Robert R.
|
|
2007
|
|
5S1 |
p. S40-
1 p.
|
article
|
| 133 |
Osteoporosis: Diagnosis and management today and tomorrow
|
Christiansen, C.
|
|
1995
|
|
5S1 |
p. S513-S516
4 p.
|
article
|
| 134 |
Paget’s disease from a genetic perspective
|
van Hul, W
|
|
1999
|
|
5S1 |
p. 29S-30S
nvt p.
|
article
|
| 135 |
Paget’s disease in New Zealand: Is it changing?
|
Cundy, T
|
|
1999
|
|
5S1 |
p. 7S-9S
nvt p.
|
article
|
| 136 |
Paget’s disease of bone: a review of 889 patients
|
Davie, M
|
|
1999
|
|
5S1 |
p. 11S-12S
nvt p.
|
article
|
| 137 |
Paget’s disease of bone: past and present
|
Smith, R
|
|
1999
|
|
5S1 |
p. 1S-2S
nvt p.
|
article
|
| 138 |
Paget’s disease of bone: remission and relapse after treatment
|
Grauer, A
|
|
1999
|
|
5S1 |
p. 67S-
1 p.
|
article
|
| 139 |
Paget’s disease of bone: rheumatologic complications
|
Altman, R.D
|
|
1999
|
|
5S1 |
p. 47S-48S
nvt p.
|
article
|
| 140 |
Paget’s disease of bone: treatment philosophy for the twenty-first century
|
Siris, E.S
|
|
1999
|
|
5S1 |
p. 55S-56S
nvt p.
|
article
|
| 141 |
Paget’s disease with primary hyperparathyroidism: gender distribution in 30 cases, and prediction of skeletal response to parathyroidectomy in 18
|
Gutteridge, D.H
|
|
1999
|
|
5S1 |
p. 51S-
1 p.
|
article
|
| 142 |
Pamidronate in acquired immune deficiency syndrome
|
Postlethwaite, A.E
|
|
1999
|
|
5S1 |
p. 32S-
1 p.
|
article
|
| 143 |
Pamidronate in the treatment of Paget’s disease
|
Selby, P.L
|
|
1999
|
|
5S1 |
p. 57S-58S
nvt p.
|
article
|
| 144 |
Pamidronate: study of two high-dose regimens in resistant Paget’s disease of bone
|
Buckler, H.M
|
|
1999
|
|
5S1 |
p. 67S-
1 p.
|
article
|
| 145 |
Paramyxoviruses and chronic human diseases
|
Rima, B.K
|
|
1999
|
|
5S1 |
p. 23S-26S
nvt p.
|
article
|
| 146 |
Paramyxoviruses and Paget’s disease: the affirmative view
|
Mee, A.P
|
|
1999
|
|
5S1 |
p. 19S-21S
nvt p.
|
article
|
| 147 |
Pediatric bone and mineral working group
|
|
|
1998
|
|
5S1 |
p. S38-
1 p.
|
article
|
| 148 |
Perspective on the Impact of Weightlessness on Calcium and Bone Metabolism
|
Holick, M.F
|
|
1998
|
|
5S1 |
p. 105S-111S
nvt p.
|
article
|
| 149 |
Plenary lectures
|
|
|
1998
|
|
5S1 |
p. S146-
1 p.
|
article
|
| 150 |
Plenary lectures
|
|
|
2001
|
|
5S1 |
p. S66-S69
4 p.
|
article
|
| 151 |
Possible mechanisms of the analgesic action of calcitonin
|
Azria, M
|
|
2002
|
|
5S1 |
p. 80-83
4 p.
|
article
|
| 152 |
Poster presentations
|
|
|
2001
|
|
5S1 |
p. S101-S248
148 p.
|
article
|
| 153 |
Poster session III
|
|
|
1998
|
|
5S1 |
p. S83-S109
27 p.
|
article
|
| 154 |
Poster session IV
|
|
|
1998
|
|
5S1 |
p. S115-
1 p.
|
article
|
| 155 |
Post transplantation bone disease working group
|
|
|
1998
|
|
5S1 |
p. S2-
1 p.
|
article
|
| 156 |
Potential Role of rhIGF-I/IGFBP-3 in Maintaining Skeletal Mass in Space
|
Tanaka, H
|
|
1998
|
|
5S1 |
p. 145S-147S
nvt p.
|
article
|
| 157 |
Prediction and assessment of the response of Paget’s disease to bisphosphonate treatment
|
Hosking, D.J
|
|
1999
|
|
5S1 |
p. 69S-71S
nvt p.
|
article
|
| 158 |
Preface - Innovation in postmenopausal osteoporosis: A therapeutic breakthrough
|
|
|
2007
|
|
5S1 |
p. viii-
1 p.
|
article
|
| 159 |
Program: Friday, June 8, 2001
|
|
|
2001
|
|
5S1 |
p. S40-S44
5 p.
|
article
|
| 160 |
Program: Saturday, June 9, 2001
|
|
|
2001
|
|
5S1 |
p. S45-S63
19 p.
|
article
|
| 161 |
Program: Sunday, June 10, 2001
|
|
|
2001
|
|
5S1 |
p. S64-S65
2 p.
|
article
|
| 162 |
Program: Thursday, June 7, 2001
|
|
|
2001
|
|
5S1 |
p. S23-S39
17 p.
|
article
|
| 163 |
Program: Tuesday, June 5, 2001
|
|
|
2001
|
|
5S1 |
p. S1-S4
4 p.
|
article
|
| 164 |
Program: Wednesday, June 6, 2001
|
|
|
2001
|
|
5S1 |
p. S5-S22
18 p.
|
article
|
| 165 |
PTH/PTHrP and calcitonin — ligand interactions working group
|
|
|
1998
|
|
5S1 |
p. S75-
1 p.
|
article
|
| 166 |
Quantitative bone scintigraphy in the management of Paget’s disease of bone
|
Dońath, J
|
|
1999
|
|
5S1 |
p. 52S-53S
nvt p.
|
article
|
| 167 |
Renal osteodystrophy working group
|
|
|
1998
|
|
5S1 |
p. S112-
1 p.
|
article
|
| 168 |
Safety and tolerability of higher-dose intravenous bisphosphonates in metastatic breast cancer
|
Ringe, Johann D.
|
|
2007
|
|
5S1 |
p. S41-
1 p.
|
article
|
| 169 |
Satellite symposia
|
|
|
2001
|
|
5S1 |
p. S249-S254
6 p.
|
article
|
| 170 |
Severe orthopaedic complications of Paget’s disease
|
Kaplan, F.S
|
|
1999
|
|
5S1 |
p. 43S-46S
nvt p.
|
article
|
| 171 |
Short communications
|
|
|
2001
|
|
5S1 |
p. S90-S100
11 p.
|
article
|
| 172 |
Short-term therapy with oral olpadronate in very active Paget’s disease
|
Mautalen, C
|
|
1999
|
|
5S1 |
p. 93S-
1 p.
|
article
|
| 173 |
Single infusion of zoledronate in Paget’s disease of bone: a placebo-controlled, dose-ranging study
|
Buckler, H
|
|
1999
|
|
5S1 |
p. 81S-85S
nvt p.
|
article
|
| 174 |
Skeletal safety of tiludronate
|
Neer, R.M.
|
|
1995
|
|
5S1 |
p. S501-S503
3 p.
|
article
|
| 175 |
Special session for allied health professionals
|
|
|
1998
|
|
5S1 |
p. S6-S34
29 p.
|
article
|
| 176 |
Sponsored symposium
|
|
|
1998
|
|
5S1 |
p. S2-
1 p.
|
article
|
| 177 |
Sponsored symposium
|
|
|
1998
|
|
5S1 |
p. S75-
1 p.
|
article
|
| 178 |
Sponsored symposium
|
|
|
1998
|
|
5S1 |
p. S39-
1 p.
|
article
|
| 179 |
Sponsored symposium on impact of new bone assessment technologies on the management of the osteoporotic patient
|
|
|
1998
|
|
5S1 |
p. S111-
1 p.
|
article
|
| 180 |
Sponsoring organizations
|
|
|
2001
|
|
5S1 |
p. ix-x
nvt p.
|
article
|
| 181 |
Strontium ranelate: New insights into its dual mode of action
|
Marie, Pierre J.
|
|
2007
|
|
5S1 |
p. S5-S8
4 p.
|
article
|
| 182 |
Subject index
|
|
|
2001
|
|
5S1 |
p. S255-S274
20 p.
|
article
|
| 183 |
Surgical treatment of complications of Paget’s disease
|
Kenwright, J
|
|
1999
|
|
5S1 |
p. 51S-
1 p.
|
article
|
| 184 |
Table of contents
|
|
|
2001
|
|
5S1 |
p. iii-iv
nvt p.
|
article
|
| 185 |
The Gerald Aurbach memorial lecture
|
|
|
1998
|
|
5S1 |
p. S5-
1 p.
|
article
|
| 186 |
The inter-relationship between bone mineral density, turnover and structural properties in determining bisphosphonate efficacy
|
Epstein, Sol
|
|
2007
|
|
5S1 |
p. S45-
1 p.
|
article
|
| 187 |
The methodology of clinical trials of oral tiludronate in Paget's disease of bone
|
Roux, C.
|
|
1995
|
|
5S1 |
p. S497-S499
3 p.
|
article
|
| 188 |
The osteocyte working group
|
|
|
1998
|
|
5S1 |
p. S76-
1 p.
|
article
|
| 189 |
Therapeutic strategy in Paget's disease of bone
|
Meunier, P.J.
|
|
1995
|
|
5S1 |
p. S489-S491
3 p.
|
article
|
| 190 |
The reality of therapeutic adherence
|
Rizzoli, René
|
|
2007
|
|
5S1 |
p. S36-S37
2 p.
|
article
|
| 191 |
Thermal imaging in Paget’s disease of bone
|
Ring, E.F.J
|
|
1999
|
|
5S1 |
p. 53S-
1 p.
|
article
|
| 192 |
The use of risedronate in Paget’s disease
|
Miller, P.D
|
|
1999
|
|
5S1 |
p. 91S-92S
nvt p.
|
article
|
| 193 |
The worldwide problem of osteoporosis: Insights afforded by epidemiology
|
Riggs, B.L.
|
|
1995
|
|
5S1 |
p. S505-S511
7 p.
|
article
|
| 194 |
Tiludronate: Bone pharmacology and safety
|
Bonjour, J-P.
|
|
1995
|
|
5S1 |
p. S473-S477
5 p.
|
article
|
| 195 |
Tiludronate: Development as an osteoporosis therapy
|
Chesnut III, C.H.
|
|
1995
|
|
5S1 |
p. S517-S519
3 p.
|
article
|
| 196 |
Tiludronate for bone diseases Proceedings of a satellite symposium held at the XIIth international conference on calcium regulating hormones (ICCRH), Melbourne, Australia, 14 February, 1995
|
Chesnut III, C.H.
|
|
1995
|
|
5S1 |
p. S471-
1 p.
|
article
|
| 197 |
Tiludronate therapy for Paget's disease of bone
|
McClung, M.R.
|
|
1995
|
|
5S1 |
p. S493-S496
4 p.
|
article
|
| 198 |
Timetable
|
|
|
2001
|
|
5S1 |
p. xiv-
1 p.
|
article
|
| 199 |
Tolerability of less frequent dosing with ibandronate
|
Cannata-Andia, Jorge
|
|
2007
|
|
5S1 |
p. S34-S35
2 p.
|
article
|
| 200 |
Treatment of Paget’s disease of bone with alendronate
|
Lombardi, A
|
|
1999
|
|
5S1 |
p. 59S-61S
nvt p.
|
article
|
| 201 |
Treatment of Paget’s disease with tiludronate
|
Fraser, W.D
|
|
1999
|
|
5S1 |
p. 68S-
1 p.
|
article
|
| 202 |
Urinary crosslinked N-telopeptide of type I collagen and crosslaps as markers of bone resorption in patients with Paget’s disease of bone
|
Iqbal, S.J.
|
|
1999
|
|
5S1 |
p. 52S-
1 p.
|
article
|
| 203 |
Use of Calcium Tracers and Biomarkers to Determine Calcium Kinetics and Bone Turnover
|
Weaver, C.M
|
|
1998
|
|
5S1 |
p. 103S-104S
nvt p.
|
article
|
| 204 |
Vitamin D research frontiers — 1998 evening update working group
|
|
|
1998
|
|
5S1 |
p. S3-
1 p.
|
article
|
| 205 |
Welcome reception and plenary posters
|
|
|
1998
|
|
5S1 |
p. S37-
1 p.
|
article
|
| 206 |
Working group on aging and the human skeleton
|
|
|
1998
|
|
5S1 |
p. S39-
1 p.
|
article
|
| 207 |
Working group on biochemical markers of bone turnover
|
|
|
1998
|
|
5S1 |
p. S3-
1 p.
|
article
|
| 208 |
Working group on quality of life and rehabilitation in patients with osteoporosis
|
|
|
1998
|
|
5S1 |
p. S38-
1 p.
|
article
|
| 209 |
Working group on quantitative ultrasound techniques in osteoporosis
|
|
|
1998
|
|
5S1 |
p. S37-
1 p.
|
article
|
Journal description